Cargando…

Liver dysfunction associated with artificial nutrition in critically ill patients

INTRODUCTION: Liver dysfunction associated with artificial nutrition in critically ill patients is a complication that seems to be frequent, but it has not been assessed previously in a large cohort of critically ill patients. METHODS: We conducted a prospective cohort study of incidence in 40 inten...

Descripción completa

Detalles Bibliográficos
Autores principales: Grau, Teodoro, Bonet, Alfonso, Rubio, Mercedes, Mateo, Dolores, Farré, Mercé, Acosta, José Antonio, Blesa, Antonio, Montejo, Juan Carlos, de Lorenzo, Abelardo García, Mesejo, Alfonso
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147066/
https://www.ncbi.nlm.nih.gov/pubmed/17254321
http://dx.doi.org/10.1186/cc5670
_version_ 1782144353838301184
author Grau, Teodoro
Bonet, Alfonso
Rubio, Mercedes
Mateo, Dolores
Farré, Mercé
Acosta, José Antonio
Blesa, Antonio
Montejo, Juan Carlos
de Lorenzo, Abelardo García
Mesejo, Alfonso
author_facet Grau, Teodoro
Bonet, Alfonso
Rubio, Mercedes
Mateo, Dolores
Farré, Mercé
Acosta, José Antonio
Blesa, Antonio
Montejo, Juan Carlos
de Lorenzo, Abelardo García
Mesejo, Alfonso
author_sort Grau, Teodoro
collection PubMed
description INTRODUCTION: Liver dysfunction associated with artificial nutrition in critically ill patients is a complication that seems to be frequent, but it has not been assessed previously in a large cohort of critically ill patients. METHODS: We conducted a prospective cohort study of incidence in 40 intensive care units. Different liver dysfunction patterns were defined: (a) cholestasis: alkaline phosphatase of more than 280 IU/l, gamma-glutamyl-transferase of more than 50 IU/l, or bilirubin of more than 1.2 mg/dl; (b) liver necrosis: aspartate aminotransferase of more than 40 IU/l or alanine aminotransferase of more than 42 IU/l, plus bilirubin of more than 1.2 mg/dl or international normalized ratio of more than 1.4; and (c) mixed pattern: alkaline phosphatase of more than 280 IU/l or gamma-glutamyl-transferase of more than 50 IU/l, plus aspartate aminotransferase of more than 40 IU/l or alanine aminotransferase of more than 42 IU/l. RESULTS: Seven hundred and twenty-five of 3,409 patients received artificial nutrition: 303 received total parenteral nutrition (TPN) and 422 received enteral nutrition (EN). Twenty-three percent of patients developed liver dysfunction: 30% in the TPN group and 18% in the EN group. The univariate analysis showed an association between liver dysfunction and TPN (p < 0.001), Multiple Organ Dysfunction Score on admission (p < 0.001), sepsis (p < 0.001), early use of artificial nutrition (p < 0.03), and malnutrition (p < 0.01). In the multivariate analysis, liver dysfunction was associated with TPN (p < 0.001), sepsis (p < 0.02), early use of artificial nutrition (p < 0.03), and calculated energy requirements of more than 25 kcal/kg per day (p < 0.05). CONCLUSION: TPN, sepsis, and excessive calculated energy requirements appear as risk factors for developing liver dysfunction. Septic critically ill patients should not be fed with excessive caloric amounts, particularly when TPN is employed. Administering artificial nutrition in the first 24 hours after admission seems to have a protective effect.
format Text
id pubmed-2147066
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-21470662007-12-20 Liver dysfunction associated with artificial nutrition in critically ill patients Grau, Teodoro Bonet, Alfonso Rubio, Mercedes Mateo, Dolores Farré, Mercé Acosta, José Antonio Blesa, Antonio Montejo, Juan Carlos de Lorenzo, Abelardo García Mesejo, Alfonso Crit Care Research INTRODUCTION: Liver dysfunction associated with artificial nutrition in critically ill patients is a complication that seems to be frequent, but it has not been assessed previously in a large cohort of critically ill patients. METHODS: We conducted a prospective cohort study of incidence in 40 intensive care units. Different liver dysfunction patterns were defined: (a) cholestasis: alkaline phosphatase of more than 280 IU/l, gamma-glutamyl-transferase of more than 50 IU/l, or bilirubin of more than 1.2 mg/dl; (b) liver necrosis: aspartate aminotransferase of more than 40 IU/l or alanine aminotransferase of more than 42 IU/l, plus bilirubin of more than 1.2 mg/dl or international normalized ratio of more than 1.4; and (c) mixed pattern: alkaline phosphatase of more than 280 IU/l or gamma-glutamyl-transferase of more than 50 IU/l, plus aspartate aminotransferase of more than 40 IU/l or alanine aminotransferase of more than 42 IU/l. RESULTS: Seven hundred and twenty-five of 3,409 patients received artificial nutrition: 303 received total parenteral nutrition (TPN) and 422 received enteral nutrition (EN). Twenty-three percent of patients developed liver dysfunction: 30% in the TPN group and 18% in the EN group. The univariate analysis showed an association between liver dysfunction and TPN (p < 0.001), Multiple Organ Dysfunction Score on admission (p < 0.001), sepsis (p < 0.001), early use of artificial nutrition (p < 0.03), and malnutrition (p < 0.01). In the multivariate analysis, liver dysfunction was associated with TPN (p < 0.001), sepsis (p < 0.02), early use of artificial nutrition (p < 0.03), and calculated energy requirements of more than 25 kcal/kg per day (p < 0.05). CONCLUSION: TPN, sepsis, and excessive calculated energy requirements appear as risk factors for developing liver dysfunction. Septic critically ill patients should not be fed with excessive caloric amounts, particularly when TPN is employed. Administering artificial nutrition in the first 24 hours after admission seems to have a protective effect. BioMed Central 2007 2007-01-25 /pmc/articles/PMC2147066/ /pubmed/17254321 http://dx.doi.org/10.1186/cc5670 Text en Copyright © 2007 Grau et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Grau, Teodoro
Bonet, Alfonso
Rubio, Mercedes
Mateo, Dolores
Farré, Mercé
Acosta, José Antonio
Blesa, Antonio
Montejo, Juan Carlos
de Lorenzo, Abelardo García
Mesejo, Alfonso
Liver dysfunction associated with artificial nutrition in critically ill patients
title Liver dysfunction associated with artificial nutrition in critically ill patients
title_full Liver dysfunction associated with artificial nutrition in critically ill patients
title_fullStr Liver dysfunction associated with artificial nutrition in critically ill patients
title_full_unstemmed Liver dysfunction associated with artificial nutrition in critically ill patients
title_short Liver dysfunction associated with artificial nutrition in critically ill patients
title_sort liver dysfunction associated with artificial nutrition in critically ill patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147066/
https://www.ncbi.nlm.nih.gov/pubmed/17254321
http://dx.doi.org/10.1186/cc5670
work_keys_str_mv AT grauteodoro liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients
AT bonetalfonso liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients
AT rubiomercedes liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients
AT mateodolores liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients
AT farremerce liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients
AT acostajoseantonio liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients
AT blesaantonio liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients
AT montejojuancarlos liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients
AT delorenzoabelardogarcia liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients
AT mesejoalfonso liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients
AT liverdysfunctionassociatedwithartificialnutritionincriticallyillpatients